Navigation Links
NJ-Based, Minority Woman-Owned Firm Tapped to Promote Alzheimer’s Disease Drug Trial
Date:1/10/2017

Impact Consulting Enterprises, a strategic communication, marketing and public relations firm based in East Orange, N.J., has signed a deal with Suven, Inc., a Monmouth Junction, N.J.-based pharmaceutical company, to promote Suven’s launch of a clinical drug trial for SUVN-502, a promising new Alzheimer’s disease medication.

The drug trial recently began at New Jersey-based testing sites in Mercer, Monmouth and Ocean counties. Other testing sites across the country can be found on the company’s website at http://www.suvn502study.com.

“We are pleased and honored to represent Suven and its team of investigators working on this important drug trial,” said Cheryl McCants, president and CEO of Impact. “SUVN-502 could bring hope to millions of Americans living with Alzheimer’s disease. We want everyone who qualifies for the trial to participate.”

Suven is seeking people ages 50 to 85 who have been diagnosed with moderate Alzheimer’s and who are taking two standard medications for the disease - donepezil and memantine/Namenda XR®. The clinical testing is designed to examine the efficacy of SUVN-502 on mental abilities impaired by Alzheimer’s.

Scientific research has shown that people with Alzheimer’s have decreased levels of acetylcholine, a neurotransmitter in the brain essential for processing memory and learning. “SUVN-502 directly stimulates the production of this vital chemical [acetylcholine],” said Dr. Jeffrey Apter, medical director at Princeton Medical Institute and a member of the New Jersey Alzheimer’s Association Scientific Advisory Committee.

Dr. Jeffrey Apter, one of the investigators in Suven’s clinical trial, said research on new medications is essential since no new drug has been approved for Alzheimer’s in more than 20 years. “SUVN-502 offers a new mechanism to enhance drugs like Aricept when all the acetylcholine in the brain is no longer present for Aricept to work,” Apter said.

More than 5 million Americans, including 170,000 in New Jersey, are living with Alzheimer’s disease, a progressive brain disorder that slowly destroys memory and thinking skills, according to the Alzheimer’s Association. Alzheimer’s has no current cure, but treatment for symptoms are available and research continues.

Interested individuals, caregivers or physicians can visit http://www.suvn502study.com to pre-qualify themselves, loved ones or patients for participation. People may also call Impact’s offices at 973-337-2028 or the Princeton Medical Institute at 609-921-6050 for additional information.

Impact Consulting Enterprises is a minority- and woman-owned strategic communication, marketing and public relations firm. McCants was recently named as one of the country’s Top Women in PR by PRNews, as well as one of the Top 25 Leading Woman Entrepreneurs in New Jersey by Leading Women Entrepreneurs of Clinton, N.J.

###

Read the full story at http://www.prweb.com/releases/2017/01/prweb13970451.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. CEO and President at T.E.N. & CEO and Chairman at ISE® Talent, Marci McCarthy, to Moderate Key Panels at Inaugural Conference of Minority Cybersecurity Professionals
2. Concept Software & Services, Inc. receives new status as a Minority Business Graduate of Tuck’s Executive Education Minority Business Program
3. AAMC Career Fair Focuses on Minority Doctors; Panel Explores Decline of Black Males in Medicine
4. PRC: A Certified Minority Business Enterprise
5. Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities
6. Access Therapies, Inc a Nationally Minority Owned Certified Company Announces Filing an Application for Submittal to GSA in order to Win Five-Year Government Contract.
7. Sandbridge Capital Acquires a Minority Stake in BackJoy
8. Tonsillectomy Complications May Be More Likely in Poor, Minority Kids
9. Minority Neighborhoods Face Greater Exposure to Air Pollution
10. Bowers to receive GSAs 2014 Minority Mentorship Award
11. AGA showcases its commitment to improving the pipeline of minority researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains ... possible to save lost souls in the Philippines. “The Journey: From the Mountains to ... dedicated teacher of the Bible. She has taught all ages and currently teaches a ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
(Date:9/13/2017)... , Sept. 13, 2017   OrthoAtlanta has been ... Atlanta Football Host Committee (AFHC) for the 2018 College Football ... 8, 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... the AFHC "I,m In" campaign, participating in many activities leading ... ...
Breaking Medicine Technology: